Non-collagenous extracellular matrix protein (NC-ECM protein)

Non-collagenous extracellular matrix (NC-ECM) proteins are a diverse group of macromolecules, including glycoproteins, proteoglycans, and matricellular proteins, that constitute a significant portion of the extracellular environment (Frantz et al., 2010, Journal of Cell Science). Unlike structural collagens, these proteins primarily function as dynamic regulators of cell behavior by interacting with cell-surface receptors, such as integrins, and sequestering various growth factors (Theocharis et al., 2016, Advanced Drug Delivery Reviews). They play critical roles in tissue development, wound healing, and the maintenance of tissue homeostasis. In pathological conditions like cancer and fibrosis, NC-ECM proteins such as fibronectin and tenascin-C are often overexpressed or present in oncofetal isoforms, contributing to disease progression and remodeling of the microenvironment (Neri & Sondermann, 2023, Nature Reviews Immunology). Consequently, they are utilized as diagnostic biomarkers and therapeutic targets, particularly for delivering immunomodulatory agents or inhibiting pathological cell-matrix signaling. Therapeutic strategies often involve monoclonal antibodies or small molecules designed to disrupt these interactions or exploit the high local concentration of these proteins in diseased tissues (Midwood et al., 2016, Journal of Cell Science). These proteins are essential for the structural integrity of the basement membrane and interstitial matrix while facilitating signal transduction between the cell and its surroundings. Their dysregulation is a hallmark of chronic inflammatory diseases and various malignancies.

Other names

Non-collagenous proteinNCPExtracellular matrix glycoproteinProteoglycanMatricellular protein

Modulation of cell-matrix interactions, inhibition of integrin-mediated signaling, and targeted delivery of therapeutic payloads to the extracellular matrix.